Opioid-Free analgesia in Intensive Care Unit

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2022-003273-37-FR

Enrollment

Registered

2022-10-20

Start date

2022-12-19

Completion date

Unknown

Last updated

2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensive care patient requiring sedation and analgesia for invasive mechanical ventilation MedDRA version: 21.1 Level: PT Classification code 10022519 Term: Intensive care System Organ Class: 10042613 - Surgical and medical procedures

Interventions

Product Name: Paracetamol Pharmaceutical Form: Solution for infusion Product Name: Remifentanil Pharmaceutical Form: Powder for solution for injection/infusion Pharmaceutical form of the placebo: Sol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 25 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 25

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactDRCI

NIMES UNIVERSITY HOSPITAL

drc@chu-nimes.fr33466686836

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026